Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biomerica (BMRA) Interest & Investment Income (2016 - 2023)

Biomerica's Interest & Investment Income history spans 13 years, with the latest figure at $55632.0 for Q2 2023.

  • For Q2 2023, Interest & Investment Income rose 666.28% year-over-year to $55632.0; the TTM value through May 2023 reached $133000.0, up 392.59%, while the annual FY2023 figure was $133000.0, 392.59% up from the prior year.
  • Interest & Investment Income for Q2 2023 was $55632.0 at Biomerica, up from $36086.0 in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $55632.0 in Q2 2023 and bottomed at $28.0 in Q3 2022.
  • The 5-year median for Interest & Investment Income is $8037.0 (2020), against an average of $18349.1.
  • The largest annual shift saw Interest & Investment Income skyrocketed 7928.73% in 2019 before it plummeted 99.59% in 2022.
  • A 5-year view of Interest & Investment Income shows it stood at $4488.0 in 2019, then soared by 77.87% to $7983.0 in 2020, then dropped by 13.37% to $6916.0 in 2021, then soared by 496.5% to $41254.0 in 2022, then skyrocketed by 34.85% to $55632.0 in 2023.
  • Per Business Quant, the three most recent readings for BMRA's Interest & Investment Income are $55632.0 (Q2 2023), $36086.0 (Q1 2023), and $41254.0 (Q4 2022).